A recent study of the somatic mutational landscape of splicing factor genes across 33 cancer types revealed a significant association of loss-of-function (LoF) mutations affecting the remaining allele of FUBP1 with alternative splicing and gene downregulation in oligodendrogliomas [31]. The gene discussed is FUBP1; the disease is oligodendroglioma.